Switching Patients to and From XARELTO®
For patients who require anticoagulation, the summary below offers direction for converting patients between XARELTO® and warfarin, unfractionated heparin, or other anticoagulants.
*No clinical trial data are available to guide converting patients from XARELTO® to warfarin. XARELTO® affects INR, so INR measurements made during coadministration with warfarin may not be useful for determining the appropriate dose of warfarin.
†Oral or parenteral rapid-onset anticoagulants.
INR = international normalized ratio.Download Switching Chart, including Dosing Summary